SIONNA THERAPEUTICS, INC. Increase Decrease In Operating Lease Liability
SIONNA THERAPEUTICS, INC. (SION) reported Increase Decrease In Operating Lease Liability of -$1.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- SIONNA THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$544.00K.
- SIONNA THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$543.00K.
- SIONNA THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$543.00K.
- SIONNA THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$529.00K.
- SIONNA THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2025 was -$2.13M.
- SIONNA THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2024 was -$1.90M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$544.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.09M 10-Q · filed 2026-08-06 | -$1.63M derived: sum of 3 quarters · filed 2026-08-06 | -$2.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$543.00K 10-Q · filed 2026-05-12 | -$1.09M derived: sum of 2 quarters · filed 2026-05-12 | -$1.61M derived: sum of 3 quarters · filed 2026-05-12 | -$2.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$543.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$1.07M derived: sum of 2 quarters · filed 2026-03-02 | -$1.60M derived: sum of 3 quarters · filed 2026-08-06 | -$2.13M 10-K · filed 2026-03-02 |
| 2025-09-30 | -$529.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.06M derived: sum of 2 quarters · filed 2026-08-06 | -$1.58M 10-Q · filed 2025-11-05 | -$2.11M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$528.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.06M 10-Q · filed 2026-08-06 | -$1.58M derived: sum of 3 quarters · filed 2026-08-06 | -$2.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$528.00K 10-Q · filed 2026-05-12 | -$1.06M derived: sum of 2 quarters · filed 2026-05-12 | -$1.57M derived: sum of 3 quarters · filed 2026-05-12 | -$2.08M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$528.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$1.04M derived: sum of 2 quarters · filed 2026-03-02 | -$1.55M derived: sum of 3 quarters · filed 2026-03-02 | -$1.90M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$514.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.03M derived: sum of 2 quarters · filed 2025-11-05 | -$1.37M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | -$513.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$855.00K 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | -$342.00K 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |